A critical advance in cancer study is arising with the use of VHH fragments to re-engage damaged p53. This essential malignant protector protein is frequently lost in many forms of tumors, leading uncontrolled cell https://getsocialselling.com/story7487360/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy